Jazz Pharmaceuticals plc — Director's Dealing 2015

Mar 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-03-03

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-03	Ordinary Shares	S	2598.0	$176.27	Disposed	21046	Direct
2015-03-04	Ordinary Shares	M	152.0	$46.83	Acquired	21198	Direct
2015-03-04	Ordinary Shares	M	5007.0	$27.46	Acquired	26205	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-04	Incentive Stock Option (right to buy)	$27.46	M	5007.0	Disposed	2021-03-09	Ordinary Shares (5007)	Direct
2015-03-04	Incentive Stock Option (right to buy)	$46.83	M	152.0	Disposed	2022-08-08	Ordinary Shares (152)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.15 to $176.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F2: The ordinary shares subject to this option fully vested as of February 7, 2015.

F3: This incentive stock option is part of an option granted on August 9, 2012 that consisted of this incentive stock option exercisable for 3,048 ordinary shares and a nonstatutory stock option exercisable for 26,952 ordinary shares. As of the date of this report, the remaining ordinary shares subject to this incentive stock option will vest with respect to 761 shares in equal monthly installments from March 9, 2015 to December 9, 2015 and with respect to 2,135 shares in equal monthly installments from January 9, 2016 to August 9, 2016.